D-0094-2024 Class III Ongoing

Recalled by Zyla Life Sciences US Inc. — Lake Forest, IL

FDA drug recall D-0094-2024 was initiated by Zyla Life Sciences US Inc. on Oct 20, 2023 and is designated Class III. Reason for recall: Sub-potent Drug: Lower potency than labeled. The recall status is ongoing. Affected quantity: 3,792 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 15, 2023
Initiation Date
Oct 20, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,792 bottles

Product description

Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11

Reason for recall

Sub-potent Drug: Lower potency than labeled.

Distribution pattern

Nationwide

Code information

Lot 22W02, Exp 01/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0094-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0094-2024. Report a data issue: hello@regdatalab.com.